data_1hnr_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1hnr _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.9 57.57 5.07 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.803 0.441 . . . . 0.0 110.208 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.9 mmp_? -120.0 100.27 48.41 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -60.61 -31.5 92.27 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.463 2.109 . . . . 0.0 111.014 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.85 70.21 2.58 Favored 'General case' 0 C--N 1.342 0.282 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -84.5 -11.07 56.82 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.45 0.3 . . . . 0.0 110.205 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.43 136.06 39.43 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.9 t -110.29 155.29 22.27 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 122.607 0.363 . . . . 0.0 110.092 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -123.65 154.17 39.74 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.0 t -135.97 125.38 39.82 Favored 'Isoleucine or valine' 0 C--N 1.339 0.117 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -109.64 -166.96 1.14 Allowed 'General case' 0 C--N 1.341 0.208 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 -63.33 -42.93 99.0 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.191 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -66.91 -49.05 66.78 Favored 'General case' 0 C--N 1.342 0.276 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 117.99 40.8 0.68 Allowed Glycine 0 C--N 1.34 0.751 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -78.45 71.12 4.89 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.4 m -69.98 81.37 0.48 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -132.23 165.82 23.26 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.0 p -64.12 155.91 30.03 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 37.7 m0 -62.28 -64.19 1.0 Allowed 'General case' 0 C--N 1.343 0.326 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.7 t 41.5 -149.48 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.852 0.861 . . . . 0.0 110.966 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.21 -82.83 0.34 Allowed Glycine 0 C--N 1.341 0.846 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 14.3 mp0 -127.16 -9.28 5.89 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.778 0.431 . . . . 0.0 110.019 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 65.61 69.4 1.36 Allowed Glycine 0 C--N 1.345 1.044 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -155.21 -177.56 6.63 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.3 m -120.63 88.7 43.74 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -65.41 -73.68 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.568 2.179 . . . . 0.0 111.541 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -159.13 -38.88 0.06 Allowed 'General case' 0 C--O 1.223 -0.314 0 CA-C-O 119.755 -0.164 . . . . 0.0 111.236 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 84.5 t -49.6 -54.02 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 122.447 0.299 . . . . 0.0 110.616 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.2 mt -59.09 -48.96 85.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 122.456 0.302 . . . . 0.0 110.322 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -57.39 -43.79 83.93 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.331 0.252 . . . . 0.0 110.511 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -61.76 -54.34 43.7 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.61 -36.97 72.47 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 58.7 ttp -66.55 -47.81 71.68 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -63.15 -46.96 84.77 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -63.16 -42.94 99.5 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.289 0.236 . . . . 0.0 110.743 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 14.6 tp60 -127.98 -79.12 0.58 Allowed 'General case' 0 C--N 1.344 0.35 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 39.31 71.88 0.24 Allowed Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.394 0.521 . . . . 0.0 112.192 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm -69.6 -50.41 44.76 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 39.8 t -152.39 -176.79 5.85 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 88.7 mt -65.32 -28.2 69.14 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -56.11 -28.18 56.81 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 123.365 0.666 . . . . 0.0 111.109 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.36 -27.02 61.9 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.358 0.263 . . . . 0.0 110.598 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -116.43 -43.64 2.92 Favored 'General case' 0 C--N 1.344 0.35 0 C-N-CA 122.378 0.271 . . . . 0.0 110.86 -178.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 42.8 tp -81.41 129.08 34.49 Favored 'General case' 0 N--CA 1.457 -0.098 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 8.5 pt -79.9 48.69 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 122.248 0.219 . . . . 0.0 110.563 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? 63.99 -73.85 0.05 OUTLIER 'General case' 0 C--N 1.349 0.573 0 C-N-CA 123.859 0.864 . . . . 0.0 110.871 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.19 0 CA-C-O 116.566 -1.683 . . . . 0.0 110.858 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.9 57.57 5.07 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.803 0.441 . . . . 0.0 110.208 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.9 mmp_? -120.0 100.27 48.41 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -60.61 -31.5 92.27 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.463 2.109 . . . . 0.0 111.014 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.85 70.21 2.58 Favored 'General case' 0 C--N 1.342 0.282 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -84.5 -11.07 56.82 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.45 0.3 . . . . 0.0 110.205 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.43 136.06 39.43 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.9 t -110.29 155.29 22.27 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 122.607 0.363 . . . . 0.0 110.092 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -123.65 154.17 39.74 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.0 t -135.97 125.38 39.82 Favored 'Isoleucine or valine' 0 C--N 1.339 0.117 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -109.64 -166.96 1.14 Allowed 'General case' 0 C--N 1.341 0.208 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 -63.33 -42.93 99.0 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.191 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -66.91 -49.05 66.78 Favored 'General case' 0 C--N 1.342 0.276 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 117.99 40.8 0.68 Allowed Glycine 0 C--N 1.34 0.751 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -78.45 71.12 4.89 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.4 m -69.98 81.37 0.48 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -132.23 165.82 23.26 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.0 p -64.12 155.91 30.03 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 37.7 m0 -62.28 -64.19 1.0 Allowed 'General case' 0 C--N 1.343 0.326 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.7 t 41.5 -149.48 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.852 0.861 . . . . 0.0 110.966 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.21 -82.83 0.34 Allowed Glycine 0 C--N 1.341 0.846 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 14.3 mp0 -127.16 -9.28 5.89 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.778 0.431 . . . . 0.0 110.019 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 65.61 69.4 1.36 Allowed Glycine 0 C--N 1.345 1.044 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -155.21 -177.56 6.63 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.3 m -120.63 88.7 43.74 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -65.41 -73.68 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.568 2.179 . . . . 0.0 111.541 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -159.13 -38.88 0.06 Allowed 'General case' 0 C--O 1.223 -0.314 0 CA-C-O 119.755 -0.164 . . . . 0.0 111.236 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 84.5 t -49.6 -54.02 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 122.447 0.299 . . . . 0.0 110.616 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.2 mt -59.09 -48.96 85.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 122.456 0.302 . . . . 0.0 110.322 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -57.39 -43.79 83.93 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.331 0.252 . . . . 0.0 110.511 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -61.76 -54.34 43.7 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.61 -36.97 72.47 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 58.7 ttp -66.55 -47.81 71.68 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -63.15 -46.96 84.77 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -63.16 -42.94 99.5 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.289 0.236 . . . . 0.0 110.743 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -127.98 -79.12 0.58 Allowed 'General case' 0 C--N 1.344 0.35 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 39.31 71.88 0.24 Allowed Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.394 0.521 . . . . 0.0 112.192 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm -69.6 -50.41 44.76 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 39.8 t -152.39 -176.79 5.85 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 88.7 mt -65.32 -28.2 69.14 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -56.11 -28.18 56.81 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 123.365 0.666 . . . . 0.0 111.109 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.36 -27.02 61.9 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.358 0.263 . . . . 0.0 110.598 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -116.43 -43.64 2.92 Favored 'General case' 0 C--N 1.344 0.35 0 C-N-CA 122.378 0.271 . . . . 0.0 110.86 -178.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 42.8 tp -81.41 129.08 34.49 Favored 'General case' 0 N--CA 1.457 -0.098 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 8.5 pt -79.9 48.69 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 122.248 0.219 . . . . 0.0 110.563 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? 63.99 -73.85 0.05 OUTLIER 'General case' 0 C--N 1.349 0.573 0 C-N-CA 123.859 0.864 . . . . 0.0 110.871 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.19 0 CA-C-O 116.566 -1.683 . . . . 0.0 110.858 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.9 57.57 5.07 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.803 0.441 . . . . 0.0 110.208 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.9 mmp_? -120.0 100.27 48.41 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -60.61 -31.5 92.27 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.463 2.109 . . . . 0.0 111.014 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.85 70.21 2.58 Favored 'General case' 0 C--N 1.342 0.282 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -84.5 -11.07 56.82 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.45 0.3 . . . . 0.0 110.205 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.43 136.06 39.43 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.9 t -110.29 155.29 22.27 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 122.607 0.363 . . . . 0.0 110.092 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -123.65 154.17 39.74 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.0 t -135.97 125.38 39.82 Favored 'Isoleucine or valine' 0 C--N 1.339 0.117 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -109.64 -166.96 1.14 Allowed 'General case' 0 C--N 1.341 0.208 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 -63.33 -42.93 99.0 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.191 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -66.91 -49.05 66.78 Favored 'General case' 0 C--N 1.342 0.276 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 117.99 40.8 0.68 Allowed Glycine 0 C--N 1.34 0.751 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -78.45 71.12 4.89 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.4 m -69.98 81.37 0.48 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -132.23 165.82 23.26 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.0 p -64.12 155.91 30.03 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 37.7 m0 -62.28 -64.19 1.0 Allowed 'General case' 0 C--N 1.343 0.326 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.7 t 41.5 -149.48 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.852 0.861 . . . . 0.0 110.966 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.21 -82.83 0.34 Allowed Glycine 0 C--N 1.341 0.846 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 14.3 mp0 -127.16 -9.28 5.89 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.778 0.431 . . . . 0.0 110.019 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 65.61 69.4 1.36 Allowed Glycine 0 C--N 1.345 1.044 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -155.21 -177.56 6.63 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.3 m -120.63 88.7 43.74 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -65.41 -73.68 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.568 2.179 . . . . 0.0 111.541 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -159.13 -38.88 0.06 Allowed 'General case' 0 C--O 1.223 -0.314 0 CA-C-O 119.755 -0.164 . . . . 0.0 111.236 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 84.5 t -49.6 -54.02 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 122.447 0.299 . . . . 0.0 110.616 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.2 mt -59.09 -48.96 85.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 122.456 0.302 . . . . 0.0 110.322 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -57.39 -43.79 83.93 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.331 0.252 . . . . 0.0 110.511 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -61.76 -54.34 43.7 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.61 -36.97 72.47 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 58.7 ttp -66.55 -47.81 71.68 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -63.15 -46.96 84.77 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -63.16 -42.94 99.5 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.289 0.236 . . . . 0.0 110.743 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 14.6 tp60 -127.98 -79.12 0.58 Allowed 'General case' 0 C--N 1.344 0.35 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 39.31 71.88 0.24 Allowed Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.394 0.521 . . . . 0.0 112.192 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm -69.6 -50.41 44.76 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 39.8 t -152.39 -176.79 5.85 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 88.7 mt -65.32 -28.2 69.14 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -56.11 -28.18 56.81 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 123.365 0.666 . . . . 0.0 111.109 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.36 -27.02 61.9 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.358 0.263 . . . . 0.0 110.598 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -116.43 -43.64 2.92 Favored 'General case' 0 C--N 1.344 0.35 0 C-N-CA 122.378 0.271 . . . . 0.0 110.86 -178.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 42.8 tp -81.41 129.08 34.49 Favored 'General case' 0 N--CA 1.457 -0.098 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 8.5 pt -79.9 48.69 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 122.248 0.219 . . . . 0.0 110.563 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? 63.99 -73.85 0.05 OUTLIER 'General case' 0 C--N 1.349 0.573 0 C-N-CA 123.859 0.864 . . . . 0.0 110.871 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.19 0 CA-C-O 116.566 -1.683 . . . . 0.0 110.858 -178.788 . . . . . . . . 1 1 . 1 stop_ save_